A randomized trial of serological and cellular responses to hepatitis B vaccination in chronic kidney disease.

A randomized trial of serological and cellular responses to hepatitis B vaccination in chronic kidney disease.

BACKGROUND:Chronic kidney disease (CKD) is associated with an increased risk of hepatitis B infection and impaired seroconversion to hepatitis B vaccine (HBV). Studies examining augmented vaccine schedules to enhance seroconversion have so far been inconclusive. Furthermore, the defects responsible...

Full description

Bibliographic Details
Main Authors: Elizabeth N da Silva, Alan Baker, Jalila Alshekaili, Krishna Karpe, Matthew C Cook
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6179249?pdf=render

Internet

http://europepmc.org/articles/PMC6179249?pdf=render

Similar Items